← Back to Clinical Trials
Recruiting NCT07285187

NCT07285187 Venous Congestion And Delirium After Cardiac Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07285187
Status Recruiting
Phase
Sponsor Zhuan Zhang
Condition Intraoperative
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2024-11-01
Primary Completion 2026-10-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
collection of demographic characteristics and comorbiditiessurgery-related parametersPOD assessments

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2024-11-01 with a primary completion date of 2026-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Postoperative delirium (POD) is an acute brain dysfunction characterized by inattention, impaired consciousness, and cognitive and orientation disturbances, and is a common complication after cardiac surgery. The high incidence of up to 52% of POD in cardiac surgery patients lead to a range of adverse clinical outcomes.The brain tissue is enclosed in a rigid anatomical structure; when there is an obstruction to venous return from the brain, intracranial pressure can increase, and blood supply to the brain tissue can decrease, leading to central nervous system dysfunction. Systemic venous congestion can occur when there is right heart dysfunction or excessive volume load. When right heart failure and/or volume overload occurs, changes in right atrial pressure are transmitted to the venous system of organs throughout the body, with dilatation of the inferior vena cava (IVC), obstruction of blood return from the hepatic, portal, and renal veins, and abnormal venous flow signals and altered ultrasound Doppler flow patterns. The primary objective of this prospective cohort study is to explore if intraoperative systemic venous congestion is associated with POD after cardiac surgery. This study will also investigate the relationship between intraoperative systemic venous congestion and postoperative complications, and the relationship between each separate venous congestion and POD after cardiac surgery.

Eligibility Criteria

Inclusion Criteria: 1. Patients scheduled to undergo elective cardiac surgery via a midline thoracic incision; 2. ≥18 years; 3. A preoperative MMSE score\>23, without consciousness or language barriers, capable of cooperating with neurological examinations, cognitive function tests, and other assessments of neurological function. Exclusion Criteria: 1. Contraindications for TEE; 2. Emergency cardiac surgery; 3. Major vascular surgery; 4. Redo cardiac surgery; 5. Severe infection requiring continuous antibiotic therapy; 6. Severe preoperative heart failure with left ventricular ejection fraction \< 30%; 7. A critical preoperative state (mechanical circulatory support, extracorporeal membrane oxygenation, current renal replacement therapy, mechanical ventilation, or cardiac arrest necessitating resuscitation); 8. Multi-organ dysfunction; 9. Known conditions that may interfere with the assessment or interpretation of hepatic vein, portal vein blood flow (such as liver cirrhosis or portal vein thrombosis) or the renal vein blood flow (such as urinary tract obstruction); 10. Planned cardiac transplantation or ventricular assist device implantation; 11. Pregnancy; 12. Insufficient ultrasonographic imaging; 13. Restarting CPB after first CPB cessation during surgery; 14. Requirement for cardiac assist devices (ECMO, IABP, or ventricular assist device) after CPB intraoperatively; 15. Neurological or psychiatric diagnoses that may affect cognitive performance or cognitive testing; 16. Documented delirium before surgery.

Contact & Investigator

Central Contact

Zhuan Zhang, MD

✉ zhangzhuancg@163.com

📞 +8615062791355

Principal Investigator

Zhuan Zhang, MD

PRINCIPAL INVESTIGATOR

The Department of Anesthesiology, The Affiliated Hospital of Yangzhou University, Yangzhou University

Frequently Asked Questions

Who can join the NCT07285187 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Intraoperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07285187 currently recruiting?

Yes, NCT07285187 is actively recruiting participants. Contact the research team at zhangzhuancg@163.com for enrollment information.

Where is the NCT07285187 trial being conducted?

This trial is being conducted at Yangzhou, China.

Who is sponsoring the NCT07285187 clinical trial?

NCT07285187 is sponsored by Zhuan Zhang. The principal investigator is Zhuan Zhang, MD at The Department of Anesthesiology, The Affiliated Hospital of Yangzhou University, Yangzhou University. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology